Industry News

Biotech

• ESMO: Zymeworks lays down marker in fight to unseat Herceptin 2021/09/16
  ESMO: Zymeworks lays down marker in fight to unseat Herceptin ntaylor Thu, 09/16/2021 – 08:28
• Aerie tries to wash over failure of midstage eye disease drug, but investors see right through it 2021/09/16
  Aerie tries to wash over failure of midstage eye disease drug, but investors see right through it badams Thu, 09/16/2021 – 04:44
• Newly discovered immune cells block melanoma metastasis in mice and could inspire new treatments 2021/09/15
  Newly discovered immune cells block melanoma metastasis in mice and could inspire new treatments arlene.weintraub Wed, 09/15/2021 – 09:58
• Abingworth, Gimv and Pfizer back stealthy Swiss startup's $61M round to crack gene therapy delivery 2021/09/15
  Abingworth, Gimv and Pfizer back stealthy Swiss startup's $61M round to crack gene therapy delivery ntaylor Wed, 09/15/2021 – 09:17
• Novo Nordisk Foundation teams up with Broad Institute, Harvard for diabetes, obesity research hub 2021/09/15
  Novo Nordisk Foundation teams up with Broad Institute, Harvard for diabetes, obesity research hub badams Wed, 09/15/2021 – 08:27

Medical Devices

Error: Feed has an error or is not valid

Pharma

• With Mirati hot on its tail, Amgen's KRAS-targeting Lumakras combo heads into late-stage colorectal cancer testing 2021/09/16
  With Mirati hot on its tail, Amgen's KRAS-targeting Lumakras combo heads into late-stage colorectal cancer testing nhigginsdunn Thu, 09/16/2021 – 11:39
• Pharma outreach to LGBTQ community lacking, reveals untapped market beyond HIV and PrEP: survey 2021/09/15
  Pharma outreach to LGBTQ community lacking, reveals untapped market beyond HIV and PrEP: survey bbulik Wed, 09/15/2021 – 18:11
• As Pfizer's booster AdComm nears, FDA staffers say COVID vaccines are already working as intended 2021/09/15
  As Pfizer's booster AdComm nears, FDA staffers say COVID vaccines are already working as intended esagonowsky Wed, 09/15/2021 – 14:29
• ESMO: Facing new Keytruda combos from Merck, BMS touts 5-year kidney cancer data for Opdivo-Yervoy 2021/09/15
  ESMO: Facing new Keytruda combos from Merck, BMS touts 5-year kidney cancer data for Opdivo-Yervoy aliu Wed, 09/15/2021 – 13:03
• ALS Ice Bucket Challenge advocacy group calls for speedy FDA approval of Amylyx now-pending drug 2021/09/15
  ALS Ice Bucket Challenge advocacy group calls for speedy FDA approval of Amylyx now-pending drug bbulik Wed, 09/15/2021 – 11:28

Vaccines

Error: Feed has an error or is not valid